SurgiSphere refuses to share data on which hydroxychloroquine study is based, forcing retraction of papers in Lancet and NEJM: bad science damages reputations of high impact journals.
SurgiSphere refuses to share data on which hydroxychloroquine study is based, forcing retraction of papers in Lancet and NEJM: bad science damages reputations of high impact journals.
Coronavirus studies by Engin Akyurt via pixabay.com
The study published in both Lancet and New England Journal of Medicinehas been retracted because the primary source of the data in the study, Surgisphere, refuses to make the raw data available. It turns out that the aggregated data is implausible for several reasons, not least of which is the large number of patients it covers. Worst of all,…
View On WordPress













